Overview

Intravenous Versus Perineural Dexmedetomidine as Adjuvant in Adductor Canal Block for Total Knee Arthroplasty

Status:
Recruiting
Trial end date:
2022-07-31
Target enrollment:
Participant gender:
Summary
Shivering increases the cardiac and systemic energy expenditure, oxygen consumption and carbon dioxide production. Definitive prevention and treatment of shivering is necessary to decrease the related complications and increase post-anesthetic comfort.
Phase:
N/A
Details
Lead Sponsor:
Mansoura University
Treatments:
Dexmedetomidine
Levobupivacaine